Details of the National Institutes of Health-funded study were published this week in a Nature paper titled A brain reward circuit inhibited by next-generation weight-loss drugs in mice. In it, the team reported that they investigated the small-molecule GLP-1s including Eli Lillys recently approved drug orforglipron, also known by the brand name Foundayo, as well as danuglipron, an oral GLP-1 that was being developed by Pfizer until the company decided to discontinue its development in 2025
That means real support, real medication, and real results
Metabolism 110 , 154308 (2020)
Standard ground shipping in summer months can expose packages to cargo hold temperatures exceeding 40C for 2448 hours
Hair thinning deserves a brief, calm mention because it worries women more than almost any other possible effect
They help dissolve fat in targeted areas, giving a slimmer look